forked from jackbibby1/SCPA
-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathREADME.Rmd
73 lines (48 loc) · 3.88 KB
/
README.Rmd
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
---
output: github_document
---
<!-- README.md is generated from README.Rmd. Please edit that file -->
```{r, include = FALSE}
knitr::opts_chunk$set(
collapse = TRUE,
comment = "#>",
fig.path = "man/figures/",
out.width = "100%"
)
```
<!-- badges: start -->
<!-- badges: end -->
# Single Cell Pathway Analysis <img src="man/figures/logo.png" align="right" width=80px/>
![](man/figures/scpa_outline.png)
### On this page
1. A brief [overview](https://jackbibby1.github.io/SCPA/#about-scpa) of SCPA
2. Package [installation](https://jackbibby1.github.io/SCPA/#installation)
3. Links to [tutorials](https://jackbibby1.github.io/SCPA/#tutorials)
4. Submitting [issues/comments](https://jackbibby1.github.io/SCPA/#issues)
### About SCPA
SCPA is a method for pathway analysis in single cell RNA-seq data. It's a novel approach to pathway analysis that defines pathway activity as a change in multivariate distribution of a given pathway across conditions, rather than enrichment or over representation of genes.
Overall the workflow looks like this: generate the populations and pathways to compare > SCPA generates pathway specific expression matrices for all comparisons > SCPA performs graph based multivariate distribution analysis across all pathways and populations > SCPA generates a Qval for plotting and ranking of pathway.
This approach allows for a number of benefits over current methods, including:
1. You will identify pathways that show enrichment in a given population AND also identify pathways with no overall enrichment but alterations in the multivariate distribution of that pathway. You essentially get the best of both worlds, as pathways with changes in multivariate distribution but no overall enrichment are still interestingly different pathways, as we show in [our paper](https://www.biorxiv.org/content/10.1101/2022.02.07.478807v1)
1. SCPA allows for multisample testing, so you can compare multiple conditions simultaneously e.g. compare across 3 time points, or across multiple phases of a [pseuodotime trajectory](https://jackbibby1.github.io/SCPA/articles/pseudotime.html). This means you can assess pathway activity through multiple stimulation phases, or across cell differentiation
To see the stats behind SCPA, you can see our paper in JASA [here](https://www.tandfonline.com/doi/full/10.1080/01621459.2020.1791131)
Our paper introducing SCPA and demonstrating its use on a T cell scRNA-seq dataset
is currently on bioRxiv [here](https://www.biorxiv.org/content/10.1101/2022.02.07.478807v1)
### Installation
You can install SCPA by running:
``` r
# install.packages("devtools")
devtools::install_github("jackbibby1/SCPA")
```
### Tutorials
If you're viewing this page on GitHub, the SCPA webpage with all the documentation and tutorials is [here](https://jackbibby1.github.io/SCPA/)
We have various examples and walkthroughs, including:
- A generic quick start [tutorial](https://jackbibby1.github.io/SCPA/articles/quick_start.html)
- A [tutorial](https://jackbibby1.github.io/SCPA/articles/using_gene_sets.html) on how to get and use gene sets with SCPA
- A [tutorial](https://jackbibby1.github.io/SCPA/articles/comparing_two_populations.html) for more detailed two group comparison with a specific data set
- A [tutorial](https://jackbibby1.github.io/SCPA/articles/seurat_comparison.html) on how to use SCPA directly within a Seurat object
- A [tutorial](https://jackbibby1.github.io/SCPA/articles/pseudotime.html) for multisample SCPA, comparing pathways across a pseudotime trajectory
- A [tutorial](https://jackbibby1.github.io/SCPA/articles/systematic_tissue_comparison.html) of a systematic analysis of many cell types across multiple tissues
- A [tutorial](https://jackbibby1.github.io/SCPA/articles/disease_comparison.html) for a systems level analysis of many cells types in disease (COVID-19)
### Issues
To report any issues or submit comments please use: https://github.com/jackbibby1/SCPA/issues